GLUCAGON ANALOGUES

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TOLBORG, JAKOB LIND, RIBER, DITTE, HAMPRECHT, DIETER WOLFGANG
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TOLBORG, JAKOB LIND
RIBER, DITTE
HAMPRECHT, DIETER WOLFGANG
description The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL3057983TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL3057983TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL3057983TT33</originalsourceid><addsrcrecordid>eNrjZBBy9wl1dnT391Nw9HP08XcPdQ3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT7GBqbmlhbGISHGxsSoAQBJEx6Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLUCAGON ANALOGUES</title><source>esp@cenet</source><creator>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</creator><creatorcontrib>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</creatorcontrib><description>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</description><language>eng ; pol</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200518&amp;DB=EPODOC&amp;CC=PL&amp;NR=3057983T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200518&amp;DB=EPODOC&amp;CC=PL&amp;NR=3057983T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOLBORG, JAKOB LIND</creatorcontrib><creatorcontrib>RIBER, DITTE</creatorcontrib><creatorcontrib>HAMPRECHT, DIETER WOLFGANG</creatorcontrib><title>GLUCAGON ANALOGUES</title><description>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBBy9wl1dnT391Nw9HP08XcPdQ3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxAT7GBqbmlhbGISHGxsSoAQBJEx6Y</recordid><startdate>20200518</startdate><enddate>20200518</enddate><creator>TOLBORG, JAKOB LIND</creator><creator>RIBER, DITTE</creator><creator>HAMPRECHT, DIETER WOLFGANG</creator><scope>EVB</scope></search><sort><creationdate>20200518</creationdate><title>GLUCAGON ANALOGUES</title><author>TOLBORG, JAKOB LIND ; RIBER, DITTE ; HAMPRECHT, DIETER WOLFGANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL3057983TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>TOLBORG, JAKOB LIND</creatorcontrib><creatorcontrib>RIBER, DITTE</creatorcontrib><creatorcontrib>HAMPRECHT, DIETER WOLFGANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOLBORG, JAKOB LIND</au><au>RIBER, DITTE</au><au>HAMPRECHT, DIETER WOLFGANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLUCAGON ANALOGUES</title><date>2020-05-18</date><risdate>2020</risdate><abstract>The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; pol
recordid cdi_epo_espacenet_PL3057983TT3
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title GLUCAGON ANALOGUES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A04%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOLBORG,%20JAKOB%20LIND&rft.date=2020-05-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL3057983TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true